TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C

The aim of the research – to optimize the prediction of hepatic fibrosis (HF) progression rate in HIV-infected patients with chronic hepatitis C (CHC) based on a comprehensive assessment of general clinical, biochemical, immunological and molecular-genetic markers. Materials and methods. A cross-...

Full description

Saved in:
Bibliographic Details
Main Authors: L. M. Syzova, T. I. Koval, L. P. Kotsiubailo, O. H. Marchenko
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2019-06-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/169093/169289
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850251509368881152
author L. M. Syzova
T. I. Koval
L. P. Kotsiubailo
O. H. Marchenko
author_facet L. M. Syzova
T. I. Koval
L. P. Kotsiubailo
O. H. Marchenko
author_sort L. M. Syzova
collection DOAJ
description The aim of the research – to optimize the prediction of hepatic fibrosis (HF) progression rate in HIV-infected patients with chronic hepatitis C (CHC) based on a comprehensive assessment of general clinical, biochemical, immunological and molecular-genetic markers. Materials and methods. A cross-sectional cohort study was conducted, which included 104 HIV-infected patients with CHC. The examination program included: assessment of complaints and anamnestic data obtained by questioning and detailed analysis of medical records, physical examination, general clinical study of peripheral blood, determination of biochemical parameters of blood serum, characterizing the functional state of the liver, the level of СD4+ Т-lymphocytes, the stages of HF according to METAVIR and genetic studies (genotyping of TLR7 in order to determine the carriage of Leu allele). Results. The method of discriminant analysis showed that statistically significant informative diagnostic signs of the rapid rate of HF progression in HIV-infected patients with CHC are: lymphocytosis, the levels of AST and total bilirubin exceeding the upper limit of normal, among the concomitant pathology ‒ chronic cholecystitis, chronic pancreatitis, cholelithiasis and hepatic steatosis, the baseline level of СD4+ Т-lymphocytes less than 350 cells/mm3 and a carriage of the normal genotype (Gln/Gln, Gln/-) of the TLR7 gene. In order to optimize the prognostication of the affiliation of an HIV-infected patient with CHC to the risk group of HF rapid progression there was proposed a discriminant model of 5 risk factors (the normal genotype (Gln/Gln, Gln/-) of the TLR7 gene, the levels of total bilirubin and AST exceeding the upper limit of normal, lymphocytosis, the baseline level of СD4+ Т-lymphocytes less than 350 cells/mm3), the exact prognosis of which was 75 %. Conclusions. There was proposed an effective model that allows predicting a rapid rate of HF progression in HIV-infected patients with CHC on the basis of simple characteristics, most of which are used in routine clinical practice.
format Article
id doaj-art-7dff5d6c905e4d87b0b40ec0c0ee7dfd
institution OA Journals
issn 2306-4145
2310-1210
language English
publishDate 2019-06-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj-art-7dff5d6c905e4d87b0b40ec0c0ee7dfd2025-08-20T01:57:52ZengZaporizhzhia State Medical and Pharmaceutical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102019-06-0121332833310.14739/2310-1210.2019.3.169093TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis CL. M. SyzovaT. I. KovalL. P. KotsiubailoO. H. MarchenkoThe aim of the research – to optimize the prediction of hepatic fibrosis (HF) progression rate in HIV-infected patients with chronic hepatitis C (CHC) based on a comprehensive assessment of general clinical, biochemical, immunological and molecular-genetic markers. Materials and methods. A cross-sectional cohort study was conducted, which included 104 HIV-infected patients with CHC. The examination program included: assessment of complaints and anamnestic data obtained by questioning and detailed analysis of medical records, physical examination, general clinical study of peripheral blood, determination of biochemical parameters of blood serum, characterizing the functional state of the liver, the level of СD4+ Т-lymphocytes, the stages of HF according to METAVIR and genetic studies (genotyping of TLR7 in order to determine the carriage of Leu allele). Results. The method of discriminant analysis showed that statistically significant informative diagnostic signs of the rapid rate of HF progression in HIV-infected patients with CHC are: lymphocytosis, the levels of AST and total bilirubin exceeding the upper limit of normal, among the concomitant pathology ‒ chronic cholecystitis, chronic pancreatitis, cholelithiasis and hepatic steatosis, the baseline level of СD4+ Т-lymphocytes less than 350 cells/mm3 and a carriage of the normal genotype (Gln/Gln, Gln/-) of the TLR7 gene. In order to optimize the prognostication of the affiliation of an HIV-infected patient with CHC to the risk group of HF rapid progression there was proposed a discriminant model of 5 risk factors (the normal genotype (Gln/Gln, Gln/-) of the TLR7 gene, the levels of total bilirubin and AST exceeding the upper limit of normal, lymphocytosis, the baseline level of СD4+ Т-lymphocytes less than 350 cells/mm3), the exact prognosis of which was 75 %. Conclusions. There was proposed an effective model that allows predicting a rapid rate of HF progression in HIV-infected patients with CHC on the basis of simple characteristics, most of which are used in routine clinical practice.http://zmj.zsmu.edu.ua/article/view/169093/169289HIV infectionchronic hepatitis Cliver fibrosisprognosis
spellingShingle L. M. Syzova
T. I. Koval
L. P. Kotsiubailo
O. H. Marchenko
TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
Zaporožskij Medicinskij Žurnal
HIV infection
chronic hepatitis C
liver fibrosis
prognosis
title TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
title_full TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
title_fullStr TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
title_full_unstemmed TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
title_short TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
title_sort tlr7 gene effect on hepatic fibrosis progression rate in hiv infected patients with chronic hepatitis c
topic HIV infection
chronic hepatitis C
liver fibrosis
prognosis
url http://zmj.zsmu.edu.ua/article/view/169093/169289
work_keys_str_mv AT lmsyzova tlr7geneeffectonhepaticfibrosisprogressionrateinhivinfectedpatientswithchronichepatitisc
AT tikoval tlr7geneeffectonhepaticfibrosisprogressionrateinhivinfectedpatientswithchronichepatitisc
AT lpkotsiubailo tlr7geneeffectonhepaticfibrosisprogressionrateinhivinfectedpatientswithchronichepatitisc
AT ohmarchenko tlr7geneeffectonhepaticfibrosisprogressionrateinhivinfectedpatientswithchronichepatitisc